Search Results - Matthew Barth

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐c... by Pallawi Torka, Cory Mavis, Shalin Kothari, Sarah Belliotti, Juan Gu, Suchitra Sundaram, Matthew Barth, Francisco J. Hernandez‐Ilizaliturri

    Published in eJHaem (2020-07-01)
    Get full text
    Article


  2. 2

    Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma by John Lee, Dean Lee, Patrick Soon-Shiong, Yaya Chu, Gaurav Nayyar, Nang Kham Su, Jeremy M Rosenblum, Jeffrey T Safrit, Matthew Barth, Mitchell S Cairo

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  3. 3

    Development of an adult neurofibromatosis clinic in the comprehensive cancer center setting and descriptive analysis of the first 100 patients with neurofibromatosis type 1 by Lindsay J. Lipinski, Mary Rose Vater, Ajay Gupta, Jessica Nixon, Jacqueline A. Goldfinch, Shelby Belair, Erika Stewart, Michael Sweeney, Matthew Barth, Kenan Onel

    Published in Orphanet Journal of Rare Diseases (2026-04-01)
    Get full text
    Article


  4. 4

    686 Targeted immunotherapy and checkpoint blockade in children, adolescents, and young adults with lymphoma: RADICAL hodgkin cohort by Matthew Barth, Mitchell S Cairo, Megan S Lim, Lauren Harrison, Chitti Moorthy, Saro Armenian, Kayleigh Klose, Jessica C Hochberg, Jaclyn Baso, Ana C Xavier, Anthony N Audino, Rodney Miles, Samir Kahwash, Stephan D Voss, Suzanne Braniecki, Matthew Ehrhardt, Arvind Budhram, Ariel Stonberg, Stanton Goldman

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


Search Tools: